Funding and Investments

Jan 22, 2015
By BioPharm International Editors
Syncona and Kite Pharma announced separate investments into T-cell therapies to fight cancerous tumors.
Dec 01, 2014
BioPharm International
By BioPharm International Editors
Dalton Pharma Services announced it was awarded funding from ISTPCanada for its project to develop vaccines for respiratory syncytial virus and parainfluenza type 3.
Oct 24, 2014
Unum Therapeutics raised $12 million in Series A funding for its development of antibody-coupled T cell receptors (ACTRs) for the treatment of nonspecific tumor cells.
Jul 02, 2014
By BioPharm International Editors
OCE and OBI partner with CQDM on $3 million inter-provincial drug discovery innovation programs.
Jul 01, 2014
BioPharm International
Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.
Apr 22, 2014
By BioPharm International Editors
Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.
Apr 01, 2014
BioPharm International
Life-sciences companies continue upward momentum in 2014.
Jan 01, 2014
BioPharm International
Frenzy cools as investors seeking a quick return turn elsewhere.
Dec 16, 2013
BioPharm International
Caution should be taken when planning to crowdfund a biopharmaceutical startup.
Nov 01, 2013
BioPharm International
The JOBS Act and FDASIA show early signs of accelerating drug development.
native1_300x100
lorem ipsum